Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Pennant GroupPNTG +0.32%88 EV-to-EBITDA is 29.05 as of Jul. 30, 2026, which is 26% below its 10-year median of 39.32. GuruFocus rates PNTG with a GF Score™ of 88/100 and a GF Value™ of $35.01 (Modestly Overvalued). The stock has 8 warning signs investors should review. Among 509 Healthcare Providers & Services companies, Pennant Group ranks worse than 85.27% on this metric.
EV-to-EBITDA is calculated as enterprise value divided by its EBITDA. As of today, Pennant Group's enterprise value is $1,921 Mil.
Pennant Group's EBITDA for the trailing twelve months (TTM) ended in Mar. 2026 was $66 Mil. Therefore, Pennant Group's EV-to-EBITDA for today is 29.05.
The historical rank and industry rank for Pennant Group's EV-to-EBITDA or its related term are showing as below:
PNTG'
s EV-to-EBITDA Range Over the Past 10 Years
Min: 21.17 Med: 39.32 Max: 228.9
Current: 29.05
During the past 10 years, the highest EV-to-EBITDA of Pennant Group was 228.90. The lowest was 21.17. And the median was 39.32.
PNTG's EV-to-EBITDA is ranked worse than 85.27% of 509
companies
in the Healthcare Providers & Services industry
Industry Median: 11.01
vs PNTG: 29.05
EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.
The "classic" EV-to-EBITDA is much better in capturing debt and net cash than the PE Ratio (TTM).
Pennant Group (NAS:PNTG) EV-to-EBITDA Explanation
EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
Pennant Group's PE Ratio (TTM) for today is calculated as:
Pennant Group's share price for today is $41.13.
Pennant Group's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.850.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio (TTM).
The historical data trend for Pennant Group's EV-to-EBITDA can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Care Facilities subindustry, Pennant Group's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Pennant Group EV-to-EBITDA vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Pennant Group's EV-to-EBITDA distribution charts can be found below:
* The bar in red indicates where Pennant Group's EV-to-EBITDA falls into.
Pennant Group's current Enterprise Value is $1,921 Mil.
Pennant Group's EBITDA for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $66 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Pennant Group (PNTG) has a EV-to-EBITDA of 29.05 as of Jul. 30, 2026. EV to EBITDA ratio is the company's enterprise value divided by earnings before interest, taxes, depreciation and amortization. View historical data on Pennant Group. This is 26% below median its historical median of 39.32. Over the past decade, Pennant Group's EV-to-EBITDA has ranged from 21.17 to 228.90. According to the industry distribution chart, Pennant Group ranks #434 out of 509 companies in the Healthcare Providers & Services industry, placing it in the top 85.3%.
Is Pennant Group's EV-to-EBITDA too high?
Pennant Group's current EV-to-EBITDA of 29.05 is 26% below median its 10-year median of 39.32. Over the past 10 years, this metric has ranged from a low of 21.17 to a high of 228.90. The Healthcare Providers & Services industry median EV-to-EBITDA is 11.01. Pennant Group's value of 29.05 is 163.9% above this industry median. Based on the distribution chart, Pennant Group ranks #434 out of 509 companies in the Healthcare Providers & Services industry, which is in the bottom quartile relative to peers. Overall, Pennant Group has a GF Score™ of 88/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Pennant Group's EV-to-EBITDA compare to ARDT and HCSG?
According to the Healthcare Providers & Services industry distribution chart, Pennant Group ranks #434 out of 509 companies for EV-to-EBITDA. This places Pennant Group in the lower half of its industry. The industry median EV-to-EBITDA is 11.01. Pennant Group's value of 29.05 is 163.9% above this benchmark. Historically, Pennant Group's own EV-to-EBITDA has ranged from 21.17 to 228.90 over the past decade. While the company's 10-year median is 39.32 vs. the industry median of 11.01, Pennant Group has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-EBITDA for a Healthcare Providers & Services company?
The median EV-to-EBITDA among Healthcare Providers & Services companies is 11.01, based on 509 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-EBITDA significantly above this median, while those in the bottom quartile fall well below. However, EV-to-EBITDA should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Pennant Group's current EV-to-EBITDA of 29.05 is 163.9% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-EBITDA mean?
A high EV-to-EBITDA can signal that a stock is expensive relative to its fundamentals. EV to EBITDA ratio is the company's enterprise value divided by earnings before interest, taxes, depreciation and amortization. View historical data on Pennant Group. For the Healthcare Providers & Services industry, the median EV-to-EBITDA is 11.01 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Pennant Group's current EV-to-EBITDA is 29.05, which is 26% below median its own 10-year median of 39.32. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Pennant Group stock overvalued right now?
Based on GuruFocus' analysis, Pennant Group (PNTG) is currently considered Modestly Overvalued. The stock's GF Value™ is $35.01, compared to a current price of $41.13 — trading 17.5% above its estimated fair value. The current EV-to-EBITDA is 29.05, which is 26% below median its 10-year median of 39.32 and 163.9% above the Healthcare Providers & Services industry median of 11.01. Pennant Group's overall GF Score™ is 88/100 with 8 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-EBITDA calculated?
EV-to-EBITDA is calculated from a company's financial statements. For Pennant Group (PNTG), the current EV-to-EBITDA is 29.05 as of Jul. 30, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Pennant Group (PNTG) Overvalued in 2026?
Based on GuruFocus' analysis, Pennant Group stock appears to be overvalued.
The current stock price of $41.13 is trading 17.5% above its estimated GF Value™ of $35.01.
GuruFocus considers Pennant Group to be Modestly Overvalued.
Key valuation signals for PNTG:
EV-to-EBITDA: 29.05 (26% below median its 10-year median of 39.32)
GF Value™: $35.01 vs. price of $41.13 (17.5% above fair value)
Industry Position: 163.9% above the Healthcare Providers & Services median (#434 of 509)
No single metric tells the full story. See the PNTG stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Pennant Group Inc is engaged in providing healthcare services to patients of all ages, including the growing senior population, in the United States. It operates in multiple lines of business including home health, hospice, and senior living which includes the company's assisted living, independent living, and memory care communities across Arizona, California, Colorado, Idaho, Montana, Nevada, Oklahoma, Oregon, Texas, Utah, Washington, Wisconsin, and Wyoming. It operates in two segments; home health and hospice services and senior living services. The company generates majority of its revenue from home health and hospice services segment, which includes its home health, hospice and home care businesses.
88GF Score
Get the complete analysis for PNTG
EV-to-EBITDA is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
PNTG has been successfully added to your 
